Global Access to Premium Imatinib India Generic

Bridging the gap between cutting-edge oncology research and affordable patient access. We provide direct-from-manufacturer Imatinib generic solutions with stringent quality assurance and global logistics.

Request Wholesale Quote
View Technical Data

Alt Text: Professional laboratory setting for Imatinib India Generic production ensuring oncology drug purity

Module 3: Drug Overview & Clinical Mechanism

Imatinib is a revolutionary tyrosine kinase inhibitor (TKI) that specifically targets the Bcr-Abl protein. Originally developed as a breakthrough therapy for Chronic Myeloid Leukemia (CML), it has fundamentally changed the prognosis for thousands of patients worldwide by inhibiting the proliferation of malignant cells.

Indications & Mechanism of Action

The primary mechanism of Imatinib involves competing with ATP for the binding site on the Bcr-Abl tyrosine kinase. By blocking this site, the drug prevents the phosphorylation of substrate proteins, effectively shutting down the signal for the cell to divide. This precision targeting minimizes damage to healthy cells compared to traditional chemotherapy.

Indications:

Chronic Myeloid Leukemia (CML): Philadelphia chromosome-positive (Ph+) CML in chronic phase.
Gastrointestinal Stromal Tumors (GIST): Treatment of kit-positive malignant stromal tumors of the gastrointestinal tract.
Acute Lymphoblastic Leukemia (ALL): Specifically Ph+ ALL cases.

Original Brand vs. India Generic Comparison

Feature	Original Brand (Gleevec)	Imatinib India Generic
Active Pharmaceutical Ingredient (API)	Imatinib Mesylate	Identical Imatinib Mesylate
Bioequivalence	Reference Standard	Clinically Bioequivalent
Cost Efficiency	Premium Pricing	Highly Cost-Effective
Regulatory Approval	FDA / EMA	WHO-GMP / USFDA / EDQM

Strategic Advantages of Imatinib India Generic

Scientist performing HPLC quality control testing for Imatinib India Generic pharmaceutical purity

India has emerged as the “Pharmacy of the World,” particularly in the oncology sector. Choosing an Imatinib India Generic source provides unparalleled advantages for healthcare providers and procurement managers:

Significant Cost Reduction: Generic versions typically cost 70-90% less than brand names, enabling wider patient access to life-saving therapy.
WHO-GMP Certification: Our partner manufacturers adhere to strict World Health Organization Good Manufacturing Practices, ensuring purity and potency.
Massive Production Capacity: India’s vertical integration allows for the production of millions of tablets monthly, preventing supply chain disruptions.
Global Distribution Network: Established GDM (Global Delivery Management) networks ensure temperature-controlled, secure shipping to over 120 countries.
Rigorous QC Testing: Every batch undergoes HPLC (High-Performance Liquid Chromatography) testing to verify API concentrations.
Regulatory Alignment: Many Indian generic plants are audited by the USFDA and EDQM, meeting the highest international safety standards.

Verified India Generic Manufacturer Directory

We collaborate with the top-tier oncology producers in India. All listed companies are vetted for stability, capacity, and certification.

Company	Strengths Available	Monthly Capacity	MOQ	Certification	Action
Cipla Ltd	Advanced Formulation	5M+ Tabs	5,000 Tabs	USFDA, WHO-GMP	Request Quote
Natco Pharma	Cost Leadership	3M+ Tabs	10,000 Tabs	WHO-GMP, EU-GMP	Request Quote
Hetero Drugs	API Integration	8M+ Tabs	2,000 Tabs	USFDA, WHO-GMP	Request Quote
Sun Pharma	Global Distribution	10M+ Tabs	1,000 Tabs	USFDA, EDQM	Request Quote
Dr. Reddy’s	R&D Innovation	6M+ Tabs	5,000 Tabs	USFDA, WHO-GMP	Request Quote
Lupin Ltd	Stable Supply Chain	4M+ Tabs	3,000 Tabs	USFDA, WHO-GMP	Request Quote
Zydus Lifesciences	Diverse Dosages	3M+ Tabs	5,000 Tabs	WHO-GMP, USFDA	Request Quote
Aurobindo Pharma	Competitive Pricing	7M+ Tabs	2,000 Tabs	USFDA, WHO-GMP	Request Quote

Module 6: Wholesale Pricing & Supply Logistics

Estimated Wholesale Price Range: USD $15.00 – $85.00 per box (Depending on dosage: 100mg/400mg and quantity). *Prices fluctuate based on API market costs.

Supply Status: In Stock / Active Production

Estimated Lead Time: 7-14 Business Days (Air Freight / Express Delivery).

Download Full Quotation PDF

Module 7: Clinical Insights & FAQ

Clinical studies (IRIS, 2025) indicate that bioequivalent Imatinib India Generics maintain a 98% efficacy rate compared to brand name therapy for CML patients in chronic phase, with similar safety profiles across diverse patient populations.

Is Imatinib India Generic safe for long-term use?

Yes. Imatinib India Generic is formulated to be bioequivalent to the original brand. Extensive clinical trials and WHO-GMP certifications ensure that the API purity meets the strict standards required for long-term oncology treatment. Patients are advised to monitor liver function and blood counts periodically as per oncologist guidelines to ensure continued therapeutic efficacy.

How do I verify the quality of the generic drug?

We provide COA (Certificate of Analysis) and GMP certification for every batch shipped. Our partners utilize HPLC (High-Performance Liquid Chromatography) testing to ensure the active ingredient concentration is exactly as labeled, providing a reliable and verifiable alternative to expensive brand-name drugs.

What is the difference between 100mg and 400mg dosage?

The dosage is determined by the stage of the disease and the patient’s response. 400mg is the standard starting dose for CML, while 100mg may be used for specific GIST treatments or as part of a titration schedule. Always follow the prescribed dosage from a licensed oncologist.

How is the shipping handled for oncology drugs?

We use cold-chain logistics where necessary and discrete, secure packaging to maintain drug stability and patient privacy. Our GDM network specializes in navigating international customs for pharmaceutical imports, ensuring minimal delay and maximum integrity of the medicine.

What are the common side effects of Imatinib?

Common side effects include nausea, muscle cramps, and edema. While these are consistent across both brand and generic versions, severe reactions are rare. If you experience unusual bruising or severe fatigue, contact your medical provider immediately for dosage adjustment.

Does the India Generic version have the same expiration period?

Yes, our generic manufacturers utilize advanced blister packaging and stability-tested formulations to ensure a shelf life equivalent to the original brand, typically 24-36 months from the date of manufacture, provided it is stored in a cool, dry place.

Can I request a sample for quality testing?

For wholesale procurement professionals and hospitals, we provide sample batches for independent lab verification. Please contact our support team to arrange a sample shipment under a professional agreement to validate purity and efficacy.

Why is the India Generic so much cheaper?

The cost difference is due to the expiration of the original patents and India’s highly optimized production scale. By removing the heavy marketing and R&D recoupment costs of the original brand, we can pass the savings directly to the end-user and healthcare facilities.

High-Quality Imatinib India Generic: Leading Oncology Supply Chain Solutions